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Chapter 17
Impact of outcomes research on the management
of vascular surgery patients
John E. Rectenwald, MD,a,b and Gilbert R. Upchurch, Jr, MD,a Ann Arbor, Mich
Vascular surgery has traditionally relied on prospective, randomized clinical trials, case–control series from single
institutions of excellence, and case studies to guide clinical decision-making. However, the use of a number of new clinical
research tools has allowed the vascular surgeon to more critically assess the indications for particular operations, the costs
of various procedures from both a monetary and quality-of-life standpoint, and the “real world” outcomes that can be
expected from practitioners across the United States, not just from centers of excellence. Decision analysis with modeling
of cohorts with desired characteristics and vascular disease has allowed for the objective determination of procedural
cost-effectiveness and evaluation of patient quality-of-life issues surrounding vascular procedures. The use of large
national administrative databases has yielded important information concerning factors associated with improved
outcomes after several vascular procedures across the entire United States, especially after relatively uncommon
operations, such as thoracoabdominal aortic aneurysm repair. Administrative data have also enabled us to learn that
access to various new endovascular procedures is somewhat limited, especially for the uninsured or poor. Hospital and
surgeon volume, as a surrogate marker for quality, has been directly correlated with lower morbidity and mortality as well
as differences in perioperative complications after multiple vascular procedures. A certificate of added qualification in
General Vascular Surgery has also been shown to improve outcomes in patients undergoing vascular procedures. Finally,
pioneered by the Veteran’s Affairs administration and championed by the American College of Surgeons, prospectively
collected data (National Surgery Quality Improvement Program) from the Veteran’s Affairs and private sector hospitals
is providing high-quality, risk-adjusted feedback about multiple vascular procedures to the hospital and the individual
practitioner. Importantly, the body of literature generated using these new clinical research tools is being monitored by
insurers and patients, as well as by the surgeons providing the care. This ultimately will have a direct impact on practice
and referral patterns. It is therefore mandatory that vascular surgeons understand these new tools so thatwe can police our
own practices before others, such as insurance companies and hospital administrators, do it for us. (J Vasc Surg 2007;45:
131A-140A.)Traditionally, therapeutic decisions in vascular surgery
have been based on large prospective, randomized clinical
trials, case–control series from institutions of excellence,
and case reports. Although it is imperative that individual
surgeons continue to maintain their own patient and prac-
tice related outcomes, the advent of such concepts as “pay
for performance” have produced an environment where
formal outcomes-based research has rapidly come of age.
The use of large administrative databases from across the
United States has become valuable, especially in the study
of patient outcomes after several vascular operations.
Most believe the “volume outcome effect” is a surro-
gate marker for superior process variables (eg, computer
order entry, trained intensive care unit specialists, lower
nurse-to-patient ratio), but efforts to direct patients to
hospitals and surgeons with superior patient outcomes for
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in the present practice environment. For example, the
Leapfrog group, a large consortium of public and private
employers, has championed a number of financial incen-
tives to steer patients to high-volume hospitals for complex
surgical procedures.1 Although some question the practi-
cality of this approach, more insurers are beginning to refer
their patients to select surgeons and hospitals based on
surgical outcomes data. This review will address the many
new clinical research tools that have been used to assess the
care of patients undergoing vascular surgery (Table I). It is
imperative that vascular surgeons are aware of this literature
and use it to monitor their own practice.
DECISION ANALYSIS
Decision analysis is a recursive method in which certain
health states are defined and annual probabilities of devel-
oping defined health outcomes are determined. It is a good
method of determining long-term outcomes in terms of
quality of life and cost associated with chronic disease
processes. Markov decision analysis in particular lends itself
well to the study of vascular disease and has been used to
investigate carotid endarterectomy (CEA) and endovascu-
lar versus open abdominal aortic aneurysm (AAA) repair.
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Markov analysis has been used to investigate the cost-
effectiveness of CEA in asymptomatic patients.2 A recent
study used data from the Asymptomatic Carotid Athero-
sclerosis Study (ACAS)3 and assumed that patients who
experienced transient ischemic attacks or had minor strokes
crossed over into the surgical arm of the study. These
patient outcomes were modeled on data from the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET).4 Costs were estimated at $8500 for surgery
and $34,000 plus $18,000 yearly for patients with major
stroke. Cost-effectiveness was determined as the cost of
surgery per quality-adjusted life-year (QALY) saved com-
pared with medical treatment.
The authors found that surgical treatment improved
quality-adjusted life expectancy from 7.87 to 8.12 QALYs
at an incremental cost-effectiveness ratio of $8000 per
QALY saved by surgery compared with medical manage-
ment in patients with asymptomatic carotid artery disease.
They also found that 26% of medically managed asymptom-
atic patients in the model eventually became symptomatic
and required CEA. The authors concluded that for the
typical asymptomatic patient with 60% carotid stenosis,
CEA was cost-effective compared with medical therapy. A
similar study using NASCET data demonstrated cost-effec-
tiveness for patients with symptomatic carotid artery disease
and carotid stenoses of 50% to 69%.5
The impact of routine duplex surveillance after CEA on
patient outcome has also been evaluated by Markov analy-
sis. Post et al6 evaluated the practice of routine duplex
examination after CEA to detect recurrent stenosis and the
effect on QALYs, probability of stroke, and cost. They
found that the average QALY expectancy for a 66-year-old
patient was 6.31 years for a symptom-guided strategy of
surveillance at a cost of $5600 and a 13% cumulative stroke
risk. Routine yearly duplex exams for up to 5 years after
CEA resulted in similar QALYs and stroke rates, but at a
higher cost of $7300, suggesting that routine duplex sur-
veillance does not improve quality of life and is not cost-
Table I. Outcomes research tools used to assess the care
of patients with vascular disease
I. Decision analysis
A) Cost effectiveness
B) Quality of life studies
C) Impact of endovascular technology
II. Administrative data
A) “Real world” outcomes
B) Limited access to vascular care
C) Volume outcomes
i. Hospital
ii. Surgeon
D) Surgical specialization
III. Risk-adjusted, prospectively generated data
A) National Surgery Quality Improvement
Program
B) Northern New England Cardiovascular
Disease Study Groupeffective.6Similar studies have been performed for AAA repair.
One such study compared the cost effectiveness of endo-
vascular with open AAA repair7 by using a Markov decision
analysis model to calculate long-term survival rates for both
procedures in QALYs and lifetime costs for a hypothetical
group of patients who underwent open or endovascular
repair. Costs were calculated using an average cost of
$16,016 for open and $20,083 for endovascular AAA
repair. The authors found that for a 70-year-old man with a
5-cm AAA, endovascular AAA repair was cost-effective with
a cost-effectiveness ratio of $22,826. Endovascular AAA
repair remained cost-effective even if the cost of stent grafts
were increased from $8,000 to $12,000. This was largely
due to a significant reduction in morbidity and mortality
(and cost due to these) associated with this less invasive
procedure.7
Impact of endovascular technology on
surgical threshold
Decision analysis has also been used to determine the
effect of endovascular technology on the threshold for AAA
repair. Finlayson et al8 constructed a Markov decision
analysis model to calculate QALY expectance rates after
open and endovascular AAA repair and the optimal AAA
diameter for elective repair for hypothetic cohorts at aver-
age and high risk. The assumptions made for this study
were that the annual rupture risk was 0%, 1%, 11%, and 26%
for a AAAs of 4, 4.5, 5, and 6.5 cm, respectively, the
operative mortality rate for endovascular AAA repair is 1%
and 5% for open surgery in a 70-year-old man, and the risk
of conversion to open from an endovascular repair is 5%,
with a 1% yearly late conversion rate. With these assump-
tions, the authors found that the optimal AAA size thresh-
old for repair in patients at average risk with the introduc-
tion of endovascular technique did not change appreciably
nor did the QALYs added; however, for older men at high
risk, endovascular AAA repair reduces the optimal thresh-
old for repair dramatically from 8.1 to 4.7 cm, but with only
a small increase of 0.2 QALYs.8
ADMINISTRATIVE DATA
Real world outcomes
Before the advent of outcomes research, most clinical
research consisted of case–control series from institutions
of excellence with special expertise managing a specific
vascular disease or operation. The use of large, administra-
tive databases from across the United States that include
practitioners across a wide spectrum of geography, experi-
ence, and practice environment highlights the observation
that there are significant disparities in care provided to
patients with vascular disease. This appears to be true for
both common procedures, such as CEA, as well as rare
operations, such as thoracoabdominal aortic aneurysm
(TAAA) repair.
Kresowik et al,9 used the Medicare database from 1995
to 1996 to document significant variation in stroke and
death rates after CEA from 10 different states. The com-
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from 4.1% to 7.7%. Process variables associated with im-
proved outcomes following CEA included the use of intra-
operative heparin (odds ratio [OR], 0.49, P  .01), the
preoperative use of antiplatelet agents (OR, 0.70, P 
.001), and patch angioplasty (OR, 0.73, P  .003). The
combined event rate (stroke and death) of combined CEA
and coronary artery bypass grafting (CABG) was 17.4%.
The authors subsequently followed this study with a
reassessment of event rates after CEA from the same states
by comparing Medicare data from 1995 to 1996 with that
from 1998 to 1999.10 In addition, complete medical
record review for indications, care processes, and outcomes
was performed from a random sample of patients from the
same states as the Medicare data. A total of primary 9945
CEAs were included in this study. An important finding
was the combined event rate decreased significantly over
time between baseline (5.6%) and remeasurement (5.0%, P
 .05). There were persistent and significant state-to-state
variations in combined event rates for all indications. The
data also suggested that the preoperative use of antiplatelet
agents (62% to 67%; P .0001) and patching during CEA
(29% to 45%, P  .0001) had significantly increased. This
study suggested that although there was still considerable
variation between states in outcomes and process variables,
continued improvement was evident and further improve-
ment was mandated. The authors encouraged the use of
standardized, confidential outcome reporting by document-
ing that increased use of antiplatelet medications and
patching during CEA was proof of the effec-
tiveness of evidence-based performance measures.10
Although the use of large administrative databases for
common vascular procedures has been fruitful in eliciting
change, these databases have also been used to give us a
more realistic evaluation of the outcomes after the treat-
ment of uncommon and lethal diseases, such as TAAAs.
Cowan et al,11 using the National Inpatient Sample (NIS)
from 1988 to 1998, documented a staggering overall mor-
tality rate of 22.3%, with mortality improving over time
(Fig 1, A). Subgroup analysis documented that both hos-
pital and surgeon volume were predictive of mortality,
length of stay, and complications. In a follow-up study
examining patients undergoing ruptured TAAA repair,
crude survival rate in the United States was only 46%, and
this did not improve over time, with most deaths occurring
within the first 24 hours after repair12 (Fig 1, B). In a
logistic regression model, age 77 years (OR 2.5; P 
.005) was predictive of mortality, and nonwhite race (OR
0.53; P  .013) was protective.
Limited access to care
Multiple reports have documented a relationship be-
tween socioeconomic status and delayed access to care
resulting in increased mortality rates from cardiovascular
disease.13-15 This appears to be true for patients with AAA
disease as well. In a review of 5363 patients 65 years old
undergoing elective or ruptured AAA repair from 1995 to
2000, Boxer et al16 demonstrated that patients withoutinsurance (36%) or with Medicaid (18%) were more likely
to present with a ruptured AAA compared with patients
with private insurance (13%, P  .001; Fig 2, A).16 Even in
the elective setting, mortality was increased in patients
without insurance (2.6%) and with Medicaid (2.7%) com-
pared with patients with private insurance ( P  .04; Fig 2, B).
This also was true for patients undergoing ruptured aneu-
rysm repair. These data suggested that health insurance
status affects outcome after elective and ruptured open
AAA repair and that limited access to health care resulted in
more uninsured patients presenting with a ruptured AAA.
With the introduction of less invasive endovascular
therapy, administrative databases have also been used to
determine whether prejudices exist in terms of race or
income in access to this new technology. Knipp et al17
examined the diffusion of new technology for the treat-
ment of renovascular hypertension in the United States
from 1988 to 2001.17 This study documented a 73% and
Fig 1. Outcomes after a relatively uncommon vascular operation:
thoracoabdominal aortic aneurysm repair. In-hospital mortality
rate after (A) elective and (B) ruptured thoracoabdominal aortic
aneurysm repair from 1988 to 1998 in the United States. Com-
paring 1988-1993 with 1994-1998, mortality improved from (A)
25.7% to (B) 19.3% (P .002). There was no significant change in
mortality over time. (Reprinted with permission from J Vasc Surg
2002;37:1169-74 and J Vasc Surg 2003;38:319-22, 2003.)56% decrease in combined open aortic and renal revascu-
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time, respectively, whereas catheter-based therapy in-
creased 173% (0.4 to 1.1 procedures per 100,000 adults
during time period (P  .001; Fig 3). Factors predictive of
a catheter-based procedure included an acute admission,
increased age, nonwhite race, and higher income. Similarly,
Upchurch et al18 documented a rapid increase in angio-
plasty and stenting to treat patients with aortoiliac occlusive
disease from 1996 to 200018 (Fig 4). Older age, white race,
and higher income patients were more likely to undergo
catheter-based therapy for aortoiliac occlusive disease
(Table II).
Volume outcome (hospital and surgeon case volume)
Carotid endarterectomy. Of all vascular surgical pro-
cedures, few have been the subject of more critical evalua-
tion and randomized controlled trials than CEA. As a
result, CEA has been established as an effective treatment
for both asymptomatic and symptomatic carotid artery
occlusive disease.3,4,19,20 Studies using large nationally rep-
resentative databases have shown that certain operative
techniques, such as use of locoregional anesthesia and patch
angioplasty closure, lower the risk of stroke or death asso-
Fig 2. Limited access and poorer outcomes after abdominal aortic
aneurysm (AAA) repair in the United States. A, Percent of patients
with ruptured AAA repairs with private insurance, Medicaid, and no
insurance. B, In-hospital mortality for elective repair of AAA for
patients with private insurance, Medicaid, or no insurance (P .04).
(Reprinted with permission from Surgery 2003;134:142-5.)ciated with CEA.21 Unfortunately, despite leading to morestandardized indications and operative techniques for vas-
cular surgery, a considerable amount of variance in out-
comes for CEA still exists between surgeons, institutions,
and geographic areas.22,23
To better understand the causes of these variations in
outcome after CEA, many researchers have used large
national databases to establish a volume-outcome relation-
ship for CEA. Hannan et al24 used New York’s Statewide
Planning and Research administrative database to identify
28,207 patients that underwent CEA as their principle
procedure in New York State Hospitals over a 5-year period
from 1990 to 1995. The authors found a range of risk-
adjusted in-hospital mortality that was highest (1.96%) for
patients with surgeons who performed 5 CEAs annually
in hospitals that performed100 CEAs per year and lowest
Fig 3. Rapid increase of catheter-based therapy to treat renovas-
cular hypertension. There has been a 73% and 56% decline in (P
.033 and P  .001) during the 14-year study period, and angio-
plasty and stenting has increased 173% (P .001). (Reprinted with
permission from J Vasc Surg 2004;40:717-23.)
Fig 4. Rates for angioplasty and stenting or aortofemoral bypass
surgery from 1996 to 2000 in the United States. The 850%
increase in angioplasty and stenting was associated with a 34%
increase in the total number of interventions, despite the 15.5%
decrease in the number of aortofemoral bypass operations. (Re-
printed with permission from Surgery 2004;136:812-8).(0.94%) for patients with surgeons who performed 5
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were performed.24
Further study of the volume-outcome effect for CEA
has been performed using the large Medicare database.
Birkmeyer et al25 evaluated the influence of hospital vol-
ume on surgical mortality in the United States using data
from the national Medicare claims database and the Na-
tionwide Inpatient Sample.25 CEA was among five cardio-
vascular procedures and eight major cancer operations eval-
uated between the years 1994 and 1999. The total number
of procedures included in this study was approximately 2.5
million, of which about 480,000 were CEAs. Hospitals
were grouped by volume per year into very low (40
CEAs), low (40-69 CEAs), medium (70-109 CEAs), high
(110-164 CEAs) and very high (164 CEAs) and corre-
lated with operative, inpatient, and 30-day mortality. This
study showed an observed mortality rate for CEA of 2% in
very-low-volume hospitals, 1.9% in low-volume hospitals
(adjusted OR, 0.95; confidence interval (CI), 0.88 to
1.02), 1.8% in medium-volume hospitals (adjusted OR,
0.91; CI, 0.84 to 0.99), and 1.7% in both high-volume
(adjusted OR, 0.88; CI, 0.81 to 0.95) and very-high-
volume hospitals (adjusted OR, 0.88; CI, 0.80 to 0.96).
Hospital volume-outcome effects were more pronounced
for other surgical procedures studied, especially for gastrec-
tomy, esophagectomy, and pancreatic resections.25
In an effort to discern the effect of surgeon procedural
volume on surgical outcomes, a second study using infor-
mation from the national Medicare claims database was also
performed.26 The authors examined mortality among
474,108 patients who underwent one of eight cardiovas-
cular procedures, including CEA, from 1998 through
1999. Using nested regression models, they were able to
discern the relationship between operative mortality, sur-
geon volume, and hospital volume, with adjustment for
patient and provider characteristics. For patients undergo-
ing CEA, adjusted mortality rates were 1.8% for low-
Table II. Characteristics associated with increased use of
angioplasty and stenting compared with aortofemoral
bypass for 1996 to 2000 in the United States
Characteristic Increased utilization OR (95% CI)
Age, years*
51 to 60 1.30 (0.94 to 1.11)
61 to 70 1.70 (1.22 to 1.43)
71 to 80 2.81 (2.0 to 2.39)
80 6.38 (3.94 to 5.01)
White race 1.38 (1.02 to 1.19)
Income†
$25,000-$39,999 1.63 (1.19 to 1.39)
$40,000-$49,999 1.66 (1.20 to 1.41)
$50,000 1.70 (1.24 to 1.45)
OR, Odds ratio; CI, confidence interval.
(Reprinted with permission from Surgery 2004;136:812-8).
*Compared with age 50 years.
†Compared with $25,000.volume surgeons performing 18 CEAs yearly, 1.3% formedium-volume surgeons performing between 18 and 40
CEAs yearly, and 1.1% for high-volume surgeons perform-
ing 40 CEAs yearly. Of interest was that improved out-
comes for high-volume surgeons did not appear to be
influenced by the volume status of the hospital, suggesting
that the effect on operative outcomes was entirely a sur-
geon-volume effect for CEA.
In another similar study of 35,821 patients undergoing
CEA from the National Inpatient Sample between 1996
and 1997, Cowan et al27 showed that high-volume sur-
geons perform 52% of all CEAs annually in the United
States.27 High-volume surgeons (30 CEAs yearly) had an
observed mortality rate of 0.44% compared with a 0.63%
rate for medium-volume surgeons (10 to 29 CEAs yearly)
and 1.1% for low-volume surgeons (10 CEAs yearly;
Fig 5.) The postoperative stroke rate was 1.14% for high-
volume surgeons compared with 1.63% for medium-
volume and 2.03% for low-volume surgeons (P  0.001).
This study found that surgeon specialty had no affect on
mortality or perioperative stroke rates, and low yearly hos-
pital CEA volume (100 CEAs) did not affect outcomes.27
Abdominal aortic aneurysm repair. The last half-
century has seen dramatic improvement in the diagnosis,
management, and treatment of AAA disease. The advent of
endovascular techniques for AAA repair has added signifi-
cantly to the armamentarium of AAA treatment, creating
options for patients who otherwise could not undergo
repair safely. Improved anesthesia and postoperative inten-
sive care, as well as refined surgical techniques, have signif-
icantly decreased morbidity and mortality associated with
surgical treatment of AAA, with a current reported mortal-
ity rate of 4.7% for unruptured and 40.7% for ruptured
open AAA repairs, and a mortality rate of 1% for elective
and 35.3% for ruptured endovascular AAA repair.28 Cur-
rent efforts to study and improve patient outcomes after
AAA repair have increasingly involved the use of large
administrative databases and identification of factors that
alter morbidity and mortality associated with AAA repair.
As with CEA, hospital and surgeon volume appears to
affect patient outcome after AAA repair. Comparing hospi-
tal volume with surgical mortality, Birkmeyer et al25 evalu-
ated 140,577 elective AAA operations and stratified risk
adjusted outcomes by hospital volume. Hospital yearly
volume was grouped into very low (17 AAAs), low (17 to
30 AAAs) medium (31 to 49 AAAs), high (50 to 79 AAAs),
and very high (79 AAAs) and correlated with operative,
inpatient, and 30-day mortality. This study showed an
observed mortality rate for AAA repair of 7.8% in very-low-
volume hospitals, 5.9% in low-volume hospitals (adjusted
OR 0.79; CI, 0.73 to 0.86), 5.2% in medium-volume
hospitals (adjusted OR, 0.70; CI, 0.64 to 0.76), 5.3% in
high-volume (adjusted OR, 0.71; CI, 0.65 to 0.78), and
4.4% in very-high-volume hospitals (adjusted OR 0.58, CI
0.53 to 0.96). Adjusted mortality rates showed a similar
distribution, suggesting better outcomes in high-volume
hospitals compared with low-volume hospitals for AAA
repair.25
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AAA outcomes was also determined.26 In this second
study, the authors examined mortality among 474,108
Fig 5. Impact of surgeon volume after carotid endarterectomy
(CEA). A, In-hospital mortality, (B) Postoperative stroke rate,
and (C) Prolonged length of stay (4 days) for surgeons with
different annual CEA caseload volume. (Reprinted with permis-
sion from J Am Coll Surg 2002;195:814-21.)patients who underwent one of eight cardiovascular proce-dures (including AAA repair) or cancer resections from
1998 through 1999. The authors were able to discern the
relationship between operative mortality, surgeon volume,
and hospital volume, with adjustment for patient and pro-
vider characteristics. For patients undergoing elective AAA
repair, adjusted mortality rates were 6.2% for low-volume
surgeons (8 yearly), 4.6% for medium-volume surgeons
(8 to 17.5 yearly), and 3.9% for high-volume surgeons
(17.5 yearly). Similar to CEA, outcomes for individual
surgeons did not appear to be influenced significantly by
the hospital’s volume status.26
Lower extremity bypass surgery. The volume-out-
come relationship for lower extremity bypass surgery
(LEBS) has been investigated, but has been difficult to
assess owing to the complexity of studying the multiple
technique variations and the wide spectrum of peripheral
vascular occlusive disease. Despite this, attempts have been
made to determine if a volume-outcome relationship exists
for LEBS.
An initial study evaluated 263,580 LEBS and stratified
risk-adjusted outcomes by hospital volume.25 Hospitals
were grouped by yearly volume of LEBS into very low
(22), low (22 to 39) medium (40 to 60), high (61 to 94),
and very high (94) and correlated with operative, inpa-
tient, and 30-day mortality. This study showed an observed
mortality rate for LEBS of 6.1% in very-low-volume hospi-
tals, 5.8% in low-volume hospitals (adjusted OR, 0.94; CI,
0.89 to 1.0), 5.5% in medium-volume hospitals (adjusted
OR, 0.90; CI 0.85 to 0.97), 5.5% in high-volume hospitals
(adjusted OR, 0.94; CI, 0.87 to 1.01), and 4.9% in very-
high-volume hospitals (adjusted OR, 0.81; CI 0.74 to
0.88). Adjusted mortality rates were 5.1%, 4.8%, 4.6%,
4.8%, and 4.1% for very-low to very-high-volume hospitals,
respectively.25
A recent meta-analysis examining several surgical pro-
cedures and the relationship of procedure volume with
outcome identified only two reports that pertained to
LEBS. Only one of these two studies documented a statis-
tically significant relationship between hospital volume and
improved outcomes in patients undergoing LEBS. The
authors identified an absolute difference in mortality of
1.1% for high-volume and 1.4% for low-volume hospitals
for patients undergoing LEBS.29
Surgical specialization
Carotid endarterectomy. Factors other than the vol-
ume of CEAs performed have an impact on patient out-
come. Surgical subspecialty training has also been exam-
ined critically. In a retrospective cohort study, Hannan
et al30 examined the variation in practice patterns, processes of
care, and outcome for patients undergoing CEA. They
analyzed data from a voluntary registry of 3644 patients
undergoing CEA during a 2-year period from 1997 to
1999 in New York State Hospitals. The overall adverse
outcome of in-hospital stroke and death was 1.84%, and the
mortality rate was 0.52%. After adjusting for predictors of
adverse outcomes (age, comorbidities, ipsilateral stenosis,
contralateral stenosis, and symptoms), patients of vascular
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(OR, 0.38) compared with patients undergoing CEA by
other surgeons (neurosurgeons and general surgeons, P 
.002). Of interest was that after adjusting for specific pro-
cesses measures, such as the use of protamine, eversion
endarterectomy, and the use of carotid shunts, patients
receiving more than one of these measures had a decreased
risk of an adverse outcome compared with those who had
none (OR, 0.43; P  .002), and surgical specialty also was
no longer a significant determiner of outcome.30
A second study from Canada in 2002 attempted to
simultaneously assess associations between hospital case
volume, teaching status, clinical trial participation, surgeon
specialty, and case volume with outcome after CEA.31 The
authors evaluated all patients in the Canadian administra-
tive hospital discharge database who underwent CEA from
1994 to 1997 and found an inverse relationship between
both surgeon and hospital case volume and in hospital
stroke or death. Low-volume surgeons in low-volume hos-
pitals had a relative risk of 3.5 for a poorer outcome
compared with high-volume surgeons in high-volume hos-
pitals. Teaching status of the hospital had no association
with improved outcomes, but clinical trial participation
predicted better outcomes. Patients of general surgeons
faired worse than surgical specialists.31
A certificate of added qualification in General Vascular
Surgery has also been shown to be associated with im-
proved outcomes after CEA. Pearce et al32 used the Inter-
national Classification of Diseases-9th Revision (ICD-9)
code to identify 45,744 patients undergoing CEA from the
Florida Agency for Health Care Administration state ad-
mission database from 1992 to 1996. The authors exam-
ined data for multiple factors, including American Board of
Surgery certification for added qualification in general vas-
cular surgery, and found that certification was a significant
predictor of better outcomes after CEA. CEA by certified
vascular surgeons was associated with 15% reduction in
death or post procedure complications (P  .002).32
Abdominal aortic aneurysm repair. Surgical special-
ization, specifically the added qualification in General Vas-
cular Surgery, has also been associated with improved out-
comes after AAA repair. Pearce et al32 identified 13,415
patients undergoing AAA repair by using the Florida
Agency for Health Care Administration state admission
database from 1992 to 1996. They found that surgeons
with added qualification in General Vascular Surgery had
significantly better outcomes after AAA repair. Certified
vascular surgeons had a 24% lower risk rate of death or
complications after AAA repair (P  .009).32
A second study of the National Inpatient Sample by
Dimick et al33 examined 3912 patients undergoing AAA
repair during 1997 and compared in-hospital mortality
between high-volume and low-volume hospitals and be-
tween high-volume and low-volume surgeons. They also
evaluated the effect of surgical specialization on outcomes
of patients undergoing AAA repair by using case mix to
define surgical specialty. This study confirmed earlier stud-
ies that suggested both hospitalization and surgery volumeaffects mortality. In addition, the authors found that vas-
cular surgeons had the lowest mortality after AAA repair
(2.2%) compared with cardiac surgeons (4.0%) and general
surgeons (5.5%, P  .001; Fig 6) AAA repair by general
surgeons, compared with vascular surgeons, was associated
with a 76% greater risk of death.33
RISK-ADJUSTED, PROSPECTIVELY
GENERATED DATA
National Veterans Administration Surgical Quality
Improvement Program
The National Veterans Administration (VA) Surgical
Quality Improvement Program (NSQIP) was created after
a Congressional mandate in 1986. It was charged with
providing a validated tool with which to monitor, compare,
and improve patient care at all 132 VA Medical Centers at
the time. The data collected included many vascular surgery
operations. Because of the high quality data and important
observations in the VA system,34 the NSQIP was privat-
ized35 and is now used in a number of non-VA hospitals.
There are many differences between this database and
administrative discharge databases. A complete review of
these differences is beyond the scope of the present article,
but some notable differences should be highlighted. Per-
manent full-time-equivalent positions, which are desig-
nated as trained surgical clinical nurse reviewers, prospec-
tively collect the data for NSQIP, which are electronically
collected and risk adjusted. Ultimately, feedback to the
providers and managers is provided with ready access to the
database for both clinical review and research.
Multiple studies focusing on patients with vascular
disease or undergoing vascular surgery procedures have
used the NSQIP database. For example, Axelrod et al36
used the NSQIP to examine the risk of stroke after elective
Fig 6. In-hospital mortality according to surgeon specialty and
high and low individual surgeon volume. Vascular specialization is
associated with significantly lower mortality rate compared to
general surgeons for both high and low volume surgeons (P 
.05). (Reprinted with permission from J Vasc Surg 2003;38:
739-44.)noncarotid vascular surgery from 1997 to 2000. The study
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to 0.6%) after noncarotid vascular surgery. When a stroke
occurred, however, it resulted in markedly increased mor-
tality and length of stay. Factors predictive of a stroke
included preoperative ventilation (OR, 11; P  .001),
history of a previous stroke or transient ischemic attack
(OR, 4.2; P  .001), postoperative myocardial infarction
(OR, 3.3; P .009), and a need to return to the operating
room (OR, 2.2; P  .001).
The unique ability of the NSQIP to stratify patients
based on comorbidities was documented in a study exam-
ining perioperative risk stratification of patients with diabe-
tes after elective vascular surgery.37 Before risk adjustment,
diabetes was predictive of both death (3.9% vs 2.6%; P 
.001) and cardiovascular complications (3.3% vs 2.6%; P
.01). When risk adjusted, however, only patients with insu-
lin-dependent diabetes were at increased risk for a cardio-
vascular complication (OR 1.48, P  .002) after vascular
surgery. Of importance was that neither insulin-dependent
nor noninsulin dependent diabetes was an independent risk
factor for mortality after risk adjustment for procedure type
and demographic factors (Table III).
Northern New England Cardiovascular Disease
Study Group
A second example of a group intended to improve
patient outcomes in patients with cardiovascular disease
merits review. The Northern New England Cardiovascular
Disease Study Group is a consortium of hospitals that
collects data in a prospective fashion for patients undergo-
ing CABG. The authors documented a threefold variation
Table III. Impact of diabetes on the risk of death after va
Risk factor*
D
Procedure type
Diabetes mellitus
Insulin-treated 1.18 (0.95-1.47)
Orally treated 0.89 (0.69-1.17)
AAA 0.45 (0.35-0.59)‡
Carotid 0.08 (0.06-0.12)‡
Lower extremity bypass 0.29 (0.23-0.38)‡
Age
On ventilator
Creatinine 2.0
CHF
On steroids
Stroke w/neuro deficit
COPD
Hypertension
AAA, Abdominal aortic aneurysm; CHF, congestive heart failure; COPD, c
Reprinted with permission from J Vasc Surg 2002;35:894-901.
*Variables not shown (P .10) sex, black race, other race, smoking, stroke w
ischemic attack. Amputation was used as the comparison procedure odds ra
†P  .05.
‡P  .01.in risk-adjusted mortality rates across the five hospitalsperforming CABG (range, 2% to 6%) and a sixfold variation
among surgeons (range, 1.6% to 10%).38
To better understand these variations, this group then
conducted site visits to focus on identifying processes of
care related to mortality. Multiple variables were noted
including (1) continuation of aspirin, -blockers, and in-
travenous heparin until incision in patients with unstable
angina, (2) maintaining hematocrits 24% during cardio-
pulmonary bypass, (3) minimizing cross-clamp time and
specific techniques related to cardioplegia, hypothermia,
and intraoperative myocardial protection, and (4) avoiding
specific inotropic drugs during and after surgery. In a
subsequent study, these processes were implemented across
the entire region, and mortality rates dropped dramatically
from 5% to 2%.39
IMPLICATIONS FOR IMPROVING THE
QUALITY OF CARE
Many policy and advocacy efforts include public report-
ing of volume and selective referral of patients for multiple
high-risk vascular procedures. Most vascular surgeons con-
demn equating volume with quality, recognizing that vol-
ume is at best a proxy for quality. Although it is possible
that some of the observed differences in mortality rates
between high-volume and low-volume providers are due to
differences in the skill of the surgeon and care team, the
practical limitation of regionalization has limited benefits
and many detractions (ie, patients and families might find
themselves long distances from home, further decline in
local regional hospitals). It is mandatory that we begin to
focus on the processes of care that leads to superior out-
r surgical procedures
adjusted odds ratio (95% confidence interval)
Additionally adjusted for
Demographic factors Comorbidities
1.25 (1.00-1.56)† 1.10 (0.85-1.41)
0.99 (0.77-1.30) 0.96 (0.73-1.28)
0.50 (0.39-0.66)‡ 0.68 (0.51-0.91)‡
0.08 (0.06-0.12)‡ 0.12 (0.07-0.17)‡
0.32 (0.25-0.42)‡ 0.42 (0.32-0.54)‡
1.05 (1.04-1.06)‡ 1.04 (1.03-1.06)‡
6.94 (3.82-12.6)‡
2.51 (1.88-3.38)‡
1.96 (1.48-2.59)‡
1.81 (1.16-2.81)‡
1.59 (1.26-2.02)‡
1.34 (1.07-1.67)‡
0.71 (0.56-0.91)‡
c obstructive pulmonary disease.
t neurological deficit, hemoglobinA1c level, alcohol use, history of transient
1.0. C statistic  0.80.scula
eath,
hroni
ithou
tio comes because this will translate into the discovery and
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improve care at all hospitals.
CONCLUSION
Outcomes research has significantly impacted surgical
management of patients with vascular disease. Decision
analysis tools have been applied to several vascular proce-
dures to address their cost-effectiveness, the quality of life
in patients after vascular surgery, and the impact of new
technology. The use of large administrative databases can
provide valuable insight into the care of the vascular pa-
tient. The most significant impact of outcomes research has
been to identify physician and hospital characteristics across
large patient populations that provide the best results for
our patients.
Many private and public institutions are aware of this
type of research and will likely refer patients to hospitals and
surgeons with “desirable characteristics,” resulting in a
selective referral process based on patient outcome or pay
for performance. Desirable characteristics at present in-
clude hospitals and surgeons with high-volume practices
for a specific vascular disease or performed by surgeons with
added qualification in General Vascular Surgery. Ongoing
prospective collection of patient data that can be risk ad-
justed (ie, NSQIP) is the present gold standard to deter-
mine indications, complication rates, and outcomes in vas-
cular patients. Although outcomes research in vascular
surgery in the past was primarily case–control series from
single institutions of excellence, present research now pro-
vides a benchmark across the entire United States for each
vascular surgeon to assess his or her own performance and
allow for critical, objective evaluation and improvements in
his or her patient’s care.
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